AK0529

AK0529 · Shanghai Ark Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AK0529, covering 2015-10-20 to 2025-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK0529 in Adults Patients Hospitalized With RSV Infection [Phase 2]